Quarterly Newsletter Q2 2022

For the second newsletter of the year, we start off by introducing to you some lesser known features of our Sanger sequencing services. From there, we'll be inviting you to learn about our capabilities in qPCR/digital PCR assay development and validation, as well as subsequent analysis of biological test objects. And we're rounding this off by, highlighting the importance of selecting the right purification method for your oligonucleotides.

Here you can read the full newsletter